Clinical Trials
14 trialsNCT03068910 2025-08-05
CRM008
University of Virginia
Phase EARLY_PHASE1 Recruiting
NCT04723862 2025-08-05
CBS010
University of Virginia
Phase EARLY_PHASE1 Recruiting
NCT05394142 2024-04-22
SPIOMET4HEALTH
Fundació Sant Joan de Déu
Phase 2 Unknown
NCT01422759 2023-10-27
Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess
University of Virginia
Phase NA Unknown
NCT04075149 2023-10-27
CBS009
University of Virginia
Phase EARLY_PHASE1 Unknown
NCT01431326 2023-09-06
PTN_POPS
Duke University
Completed
NCT06005259 2023-08-22
SPIROTOX
University of Sao Paulo
Phase 4 Unknown
NCT04190433 2023-05-24
Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial
Mayo Clinic
Phase 2 Withdrawn
NCT01867294 2020-01-09
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
Academic and Community Cancer Research United
Phase 2 Completed
NCT02689843 2019-11-12
AntiPCO
Shiraz University of Medical Sciences
Phase EARLY_PHASE1 Completed
NCT02501213 2019-05-16
Evaluation of the Efficacy of Diuretics for Symptomatic Malignant Ascites Episodes in Advanced Stage of Cancer (DIASC)
Centre Oscar Lambret
Phase 2 Terminated
NCT02531412 2017-01-04
SPIROCAN
Instituto Nacional de Cancerologia de Mexico
Phase 2/3 Unknown
NCT01526616 2012-02-06
Spironolactone Plus Metformin in Polycystic Ovary Syndrome
University Magna Graecia
Phase NA Completed
NCT00842140 2010-07-22
Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) Women
University of Sao Paulo
Phase NA Completed